In summary, this is the first study providing strong evidence of the long-term effects of AAV9-Galns treatment on the severe whole-body alterations, especially skeletal dysplasia and cartilage deterioration found in MPSIVA patients. This evidence concerns the gene GALNS and skeletal dysplasia.